We are proud to lead MolMart. We’re passionate about using the powerful technology of Genomics, to help families to make life-changing decisions at critical points in time. We lead a highly experienced team that includes Molecular Geneticists, Bioinformaticians and Genetic Counsellors. We cofounded MolMart to enable us to bring our extensive clinical and commercial expertise to as many people as possible.
Harry Kontos Ph.D, Chief Scientific Director Harry completed Post Doctorate posts at MRC-LMB, University of Cambridge and at the Dana-Farber Cancer Institute, Harvard Medical School in gene expression and gene therapy. In 2002, he founded Genomedica, a bespoke Molecular Genetics laboratory in Athens, Greece, where he has performed thousands of molecular genetic analyses. Harry's pioneering work in prenatal and pre-implantation genetics is now widely adopted and he is currently leading Whole Exome Sequencing in a diagnostic setting in Greece. Outside genetics, Harry is an elite champion long distance swimmer.
Markella Mikkelsen Ph.D, DipRCPath, Chief Business Director Markella has a First Class Honours Degree in Biology from the University of St Andrews, Scotland and a Ph.D. in nuclear spatial architecture from the University of Reading. She is an expert in Diagnostic Genetics, with a particular interest in prenatal genetics, where she has worked alongside leading names in the field. Her corporate experience includes several years in a senior commercial role in the Diagnostics industry. Outside her professional life, Markella is a competent rock-climber and mountaineer.
Savvas Neophytou Ph.D., Investment Director Savvas is a Partner and Head of Life Sciences at Deepbridge Capital. Prior to joining Deepbridge, Savvas enjoyed a 15 year career in the City, working as an investment banker at JP Morgan, Bear Stearns, Shore Capital, Cantor Fitzgerald, and Panmure Gordon. Savvas was also CEO of telemedicine business Now Healthcare Group. As a highly acclaimed analyst, Savvas has won multiple awards, most recently in 2015 when Savvas was ranked 2nd overall in the prestigious Reuters Starmine survey, a position he also held in 2014. In the same year, Savvas was also runner-up in the CityAM Analyst of the Year awards. Savvas holds a PhD in psychopharmacology from Nottingham University and a BSc (Hons) degree in pharmacology from Manchester University.
If you’d like more information about how we can help you,
give our team a call on +44 161 920 8814 or email email@example.com